These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31386267)

  • 21. Effects of Allopurinol Dose Escalation on Bone Erosion and Urate Volume in Gout: A Dual-Energy Computed Tomography Imaging Study Within a Randomized, Controlled Trial.
    Dalbeth N; Billington K; Doyle A; Frampton C; Tan P; Aati O; Allan J; Drake J; Horne A; Stamp LK
    Arthritis Rheumatol; 2019 Oct; 71(10):1739-1746. PubMed ID: 31081595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout.
    Stamp LK; Chapman PT; Barclay ML; Horne A; Frampton C; Tan P; Drake J; Dalbeth N
    Ann Rheum Dis; 2017 Sep; 76(9):1522-1528. PubMed ID: 28314755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive dietary education in treated gout patients does not further improve serum urate.
    Holland R; McGill NW
    Intern Med J; 2015 Feb; 45(2):189-94. PubMed ID: 25495503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study.
    Hosoya T; Ogawa Y; Hashimoto H; Ohashi T; Sakamoto R
    J Clin Pharm Ther; 2016 Jun; 41(3):290-7. PubMed ID: 27109450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-titration of allopurinol in patients with gout.
    Jennings CG; Mackenzie IS; Flynn R; Ford I; Nuki G; De Caterina R; Riches PL; Ralston SH; MacDonald TM;
    Semin Arthritis Rheum; 2014 Aug; 44(1):25-30. PubMed ID: 24560169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trial.
    Stamp LK; Chapman PT; Barclay M; Horne A; Frampton C; Tan P; Drake J; Dalbeth N
    Rheumatology (Oxford); 2018 Dec; 57(12):2183-2189. PubMed ID: 30107437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potency on lowering serum uric acid in gout patients: a pooled analysis of registrative studies comparing febuxostat vs. allopurinol.
    Cutolo M; Cimmino MA; Perez-Ruiz F
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4186-4195. PubMed ID: 29028079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of gout by UK rheumatologists: a British Society for Rheumatology national audit.
    Roddy E; Packham J; Obrenovic K; Rivett A; Ledingham JM
    Rheumatology (Oxford); 2018 May; 57(5):826-830. PubMed ID: 29447370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout: a randomized, open-label, multicentre, allopurinol-controlled study.
    Yu KH; Lai JH; Hsu PN; Chen DY; Chen CJ; Lin HY
    Scand J Rheumatol; 2016 Jul; 45(4):304-11. PubMed ID: 26771445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gout in a rheumatology clinic: results of EULAR/ACR guidelines-compliant treatment.
    Slot O
    Scand J Rheumatol; 2018 May; 47(3):194-197. PubMed ID: 28891365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical appraisal of serum urate targets in the management of gout.
    Stamp LK; Dalbeth N
    Nat Rev Rheumatol; 2022 Oct; 18(10):603-609. PubMed ID: 35974164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opportunities for improving medication use and monitoring in gout.
    Singh JA; Hodges JS; Asch SM
    Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A survey on the beliefs and knowledge of gout management in new medical graduates - New South Wales, Australia.
    Terrill M; Riordan J
    Int J Rheum Dis; 2018 Feb; 21(2):517-522. PubMed ID: 28544467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare system.
    Rashid N; Coburn BW; Wu YL; Cheetham TC; Curtis JR; Saag KG; Mikuls TR
    J Rheumatol; 2015 Mar; 42(3):504-12. PubMed ID: 25512479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence and persistence to urate-lowering therapies in the Irish setting.
    McGowan B; Bennett K; Silke C; Whelan B
    Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of diuretics on the urate lowering therapy in patients with gout: analysis of an inception cohort.
    Ranieri L; Contero C; Peral ML; Calabuig I; Zapater P; Andres M
    Arthritis Res Ther; 2018 Mar; 20(1):53. PubMed ID: 29566736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structured patient care pathway for gout.
    Lianes O; Nystad TW; Røen SA; Fevang BS
    Tidsskr Nor Laegeforen; 2020 Feb; 140(2):. PubMed ID: 32026858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A model-based meta-analysis to compare urate-lowering response rate of febuxostat and allopurinol in gout patient].
    Sun Y; Li L; Zhou TY; Lu W
    Yao Xue Xue Bao; 2014 Dec; 49(12):1674-83. PubMed ID: 25920196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The target uric acid level in multimorbid patients with gout is difficult to achieve: data from a longitudinal Swiss single-centre cohort.
    Ankli B; Berger CT; Haeni N; Kyburz D; Hügle T; So AK; Daikeler T
    Swiss Med Wkly; 2019 Aug; 149():w20121. PubMed ID: 31476243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.